Agenus (AGEN) Other Non-Current Liabilities (2010 - 2026)
Agenus (AGEN) posted quarterly Other Non-Current Liabilities of $247000.0 for Q1 2026, down 67.54% year-over-year from $761000.0 in Q1 2025, and down 4.63% quarter-over-quarter from $259000.0 in Q4 2025.
Agenus (AGEN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Agenus' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $247000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 67.54% year-over-year to $247000.0; the TTM figure through Mar 2026 stood at $247000.0 (down 67.54% YoY), while the FY2025 annual figure was $259000.0, down 64.91% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $247000.0, down from $259000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $14.7 million in Q4 2022, with the low at $247000.0 in Q1 2026.
- The 5-year median for Other Non-Current Liabilities is $1.5 million (2022), against an average of $3.9 million.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities soared 871.44% in 2023, then plunged 90.65% in 2024.
- Agenus' Other Non-Current Liabilities stood at $14.7 million in 2022, then plunged by 63.13% to $5.4 million in 2023, then tumbled by 86.38% to $738000.0 in 2024, then plunged by 64.91% to $259000.0 in 2025, then dropped by 4.63% to $247000.0 in 2026.
- Business Quant data shows AGEN's Other Non-Current Liabilities at $247000.0 in Q1 2026, $259000.0 in Q4 2025, and $376000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 247,000.00 |
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 752,000.00 |
| Mar 31, 2025 | 761,000.00 |
| Dec 31, 2024 | 738,000.00 |
| Sep 30, 2024 | 777,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 13.91 Mn |
| Dec 31, 2022 | 14.70 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 3.74 Mn |